
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias
Nicole Kennedy, Cullen L. Schmid, Nicolette C. Ross, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 19, pp. 8895-8907
Open Access | Times Cited: 59
Nicole Kennedy, Cullen L. Schmid, Nicolette C. Ross, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 19, pp. 8895-8907
Open Access | Times Cited: 59
Showing 1-25 of 59 citing articles:
Biased Opioid Ligands
Abdelfattah Faouzi, Balázs R. Varga, Susruta Majumdar
Molecules (2020) Vol. 25, Iss. 18, pp. 4257-4257
Open Access | Times Cited: 105
Abdelfattah Faouzi, Balázs R. Varga, Susruta Majumdar
Molecules (2020) Vol. 25, Iss. 18, pp. 4257-4257
Open Access | Times Cited: 105
The Opioid Crisis and the Future of Addiction and Pain Therapeutics
Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 371, Iss. 2, pp. 396-408
Open Access | Times Cited: 88
Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 371, Iss. 2, pp. 396-408
Open Access | Times Cited: 88
DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
István Ujváry, Rachel Christie, Michael Evans‐Brown, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1072-1092
Closed Access | Times Cited: 81
István Ujváry, Rachel Christie, Michael Evans‐Brown, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1072-1092
Closed Access | Times Cited: 81
Toward Directing Opioid Receptor Signaling to Refine Opioid Therapeutics
Travis W. Grim, Agnes Acevedo‐Canabal, Laura Bohn
Biological Psychiatry (2019) Vol. 87, Iss. 1, pp. 15-21
Open Access | Times Cited: 76
Travis W. Grim, Agnes Acevedo‐Canabal, Laura Bohn
Biological Psychiatry (2019) Vol. 87, Iss. 1, pp. 15-21
Open Access | Times Cited: 76
Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery
Samuel Obeng, Takato Hiranita, Francisco León, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 10, pp. 6523-6548
Closed Access | Times Cited: 61
Samuel Obeng, Takato Hiranita, Francisco León, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 10, pp. 6523-6548
Closed Access | Times Cited: 61
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review
Amanda L A Mohr, Barry K. Logan, Melissa F. Fogarty, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 6, pp. e116-e185
Open Access | Times Cited: 44
Amanda L A Mohr, Barry K. Logan, Melissa F. Fogarty, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 6, pp. e116-e185
Open Access | Times Cited: 44
Biased Agonism: Lessons from Studies of Opioid Receptor Agonists
Eamonn Kelly, Alexandra E. Conibear, Graeme Henderson
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 491-515
Open Access | Times Cited: 44
Eamonn Kelly, Alexandra E. Conibear, Graeme Henderson
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 491-515
Open Access | Times Cited: 44
The Rise and Fall of Isotonitazene and Brorphine: Two Recent Stars in the Synthetic Opioid Firmament
Marthe M. Vandeputte, Alex J. Krotulski, Donna M Papsun, et al.
Journal of Analytical Toxicology (2021) Vol. 46, Iss. 2, pp. 115-121
Open Access | Times Cited: 54
Marthe M. Vandeputte, Alex J. Krotulski, Donna M Papsun, et al.
Journal of Analytical Toxicology (2021) Vol. 46, Iss. 2, pp. 115-121
Open Access | Times Cited: 54
Oxidative Metabolism as a Modulator of Kratom’s Biological Actions
Soumen Chakraborty, Rajendra Uprety, Samuel T. Slocum, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 22, pp. 16553-16572
Open Access | Times Cited: 43
Soumen Chakraborty, Rajendra Uprety, Samuel T. Slocum, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 22, pp. 16553-16572
Open Access | Times Cited: 43
Low Intrinsic Efficacy Alone Cannot Explain the Improved Side Effect Profiles of New Opioid Agonists
Edward L. Stahl, Laura Bohn
Biochemistry (2021) Vol. 61, Iss. 18, pp. 1923-1935
Open Access | Times Cited: 42
Edward L. Stahl, Laura Bohn
Biochemistry (2021) Vol. 61, Iss. 18, pp. 1923-1935
Open Access | Times Cited: 42
Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide
Marthe M. Vandeputte, Meng-Hua M. Tsai, Li Chen, et al.
Drug and Alcohol Dependence (2023) Vol. 249, pp. 109939-109939
Closed Access | Times Cited: 20
Marthe M. Vandeputte, Meng-Hua M. Tsai, Li Chen, et al.
Drug and Alcohol Dependence (2023) Vol. 249, pp. 109939-109939
Closed Access | Times Cited: 20
A Bibliometric and Visual Analysis of Oliceridine Research (2013–2024)
Song Cheng, Xumin Huang, N. H. Chen, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1305-1321
Open Access
Song Cheng, Xumin Huang, N. H. Chen, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1305-1321
Open Access
Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis
Piotr F. J. Lipiński, Piotr Kossoń, Joanna Matalińska, et al.
Molecules (2019) Vol. 24, Iss. 4, pp. 740-740
Open Access | Times Cited: 51
Piotr F. J. Lipiński, Piotr Kossoń, Joanna Matalińska, et al.
Molecules (2019) Vol. 24, Iss. 4, pp. 740-740
Open Access | Times Cited: 51
In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances
Marthe M. Vandeputte, Annelies Cannaert, Christophe P. Stove
Archives of Toxicology (2020) Vol. 94, Iss. 11, pp. 3819-3830
Closed Access | Times Cited: 48
Marthe M. Vandeputte, Annelies Cannaert, Christophe P. Stove
Archives of Toxicology (2020) Vol. 94, Iss. 11, pp. 3819-3830
Closed Access | Times Cited: 48
Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors
Jolien De Neve, Thomas Barlow, Dirk Tourwé, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 6, pp. 828-870
Open Access | Times Cited: 34
Jolien De Neve, Thomas Barlow, Dirk Tourwé, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 6, pp. 828-870
Open Access | Times Cited: 34
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures
Elan Barenholtz, Alex J. Krotulski, Paul Morris, et al.
International Journal of Drug Policy (2021) Vol. 98, pp. 103393-103393
Open Access | Times Cited: 33
Elan Barenholtz, Alex J. Krotulski, Paul Morris, et al.
International Journal of Drug Policy (2021) Vol. 98, pp. 103393-103393
Open Access | Times Cited: 33
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse
Md Imdadul H. Khan, Benjamin J. Sawyer, Nicholas S. Akins, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114785-114785
Open Access | Times Cited: 27
Md Imdadul H. Khan, Benjamin J. Sawyer, Nicholas S. Akins, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114785-114785
Open Access | Times Cited: 27
Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances
Donna M Papsun, Alex J. Krotulski, Barry K. Logan
American Journal of Forensic Medicine & Pathology (2022) Vol. 43, Iss. 4, pp. 315-327
Closed Access | Times Cited: 24
Donna M Papsun, Alex J. Krotulski, Barry K. Logan
American Journal of Forensic Medicine & Pathology (2022) Vol. 43, Iss. 4, pp. 315-327
Closed Access | Times Cited: 24
Helfer, Die in Die Hölle führen können: Von Opium zu Fentanyl
Karsten Strey
Chemie in unserer Zeit (2025)
Open Access
Karsten Strey
Chemie in unserer Zeit (2025)
Open Access
Structure-guided design of partial agonists at an opioid receptor
Balázs R. Varga, Sarah M. Bernhard, Amal El Daibani, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Balázs R. Varga, Sarah M. Bernhard, Amal El Daibani, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
First Report on Brorphine: The Next Opioid on the Deadly New Psychoactive Substance Horizon?
Nick Verougstraete, Marthe M. Vandeputte, Cathelijne Lyphout, et al.
Journal of Analytical Toxicology (2020) Vol. 44, Iss. 9, pp. 937-946
Open Access | Times Cited: 37
Nick Verougstraete, Marthe M. Vandeputte, Cathelijne Lyphout, et al.
Journal of Analytical Toxicology (2020) Vol. 44, Iss. 9, pp. 937-946
Open Access | Times Cited: 37
Brorphine—Investigation and quantitation of a new potent synthetic opioid in forensic toxicology casework using liquid chromatography‐mass spectrometry
Alex J. Krotulski, Donna M Papsun, Carolina Noble, et al.
Journal of Forensic Sciences (2020) Vol. 66, Iss. 2, pp. 664-676
Closed Access | Times Cited: 37
Alex J. Krotulski, Donna M Papsun, Carolina Noble, et al.
Journal of Forensic Sciences (2020) Vol. 66, Iss. 2, pp. 664-676
Closed Access | Times Cited: 37
Plasma drug screening using paper spray mass spectrometry with integrated solid phase extraction
Hannah Zimmerman‐Federle, Greta Ren, Sarah Dowling, et al.
Drug Testing and Analysis (2024)
Open Access | Times Cited: 3
Hannah Zimmerman‐Federle, Greta Ren, Sarah Dowling, et al.
Drug Testing and Analysis (2024)
Open Access | Times Cited: 3
Progress in the development of more effective and safer analgesics for pain management
Rita Turnaturi, Santina Chiechio, Loredana Salerno, et al.
European Journal of Medicinal Chemistry (2019) Vol. 183, pp. 111701-111701
Closed Access | Times Cited: 28
Rita Turnaturi, Santina Chiechio, Loredana Salerno, et al.
European Journal of Medicinal Chemistry (2019) Vol. 183, pp. 111701-111701
Closed Access | Times Cited: 28
Addressing opioid tolerance and opioid‐induced hypersensitivity: Recent developments and future therapeutic strategies
Faris Khan, Aman Mehan
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 22
Faris Khan, Aman Mehan
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 22